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Abstract The adult heart contains a population of
cardiac progenitor cells (CPCs). Growing and collect-
ing an adequate number of CPCs demands complex
culture media containing growth factors. Since acti-
vated macrophages secrete many growth factors, we
investigated if activated isolated heart cells seeded on a
feeder layer of activated peritoneal macrophages (PM)
could result in CPCs and if these, in turn, could exert
cardioprotection in rats with myocardial infarction
(MI). Heart cells of inbred Wistar rats were isolated by
collagenase digestion and cultured on PM obtained
72 h after intraperitoneal injection of 12 ml thiogly-
collate. Cells (1 9 106) exhibiting CPC phenotype
(immunohistochemistry) were injected in the periph-
ery of rat MI 10 min after coronary artery occlusion.
Control rats received vehicle. Three weeks later, left
ventricular (LV) function (echocardiogram) was
assessed, animals were euthanized and the hearts
removed for histological studies. Five to six days after
seeding heart cells on PM, spherical clusters composed
of small bright and spherical cells expressing mostly
c-Kit and Sca-1 antigens were apparent. After explant,
those clusters developed cobblestone-like monolayers
that expressed smooth muscle actin and sarcomeric
actin and were successfully transferred for more than
ten passages. When injected in the MI periphery, many
of them survived at 21 days after coronary ligature,
improved LV ejection fraction and decreased scar size
as compared with control rats. CPC-derived cells with
cardiocyte and smooth muscle phenotypes can be
successfully grown on a feeder layer of activated
syngeneic PM. These cells decreased scar size and
improved heart function in rats with MI.
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Introduction
Evidence collected over the past several years have
shown that the adult mammalian heart contains a
population of progenitor cells (cardiac progenitor
cells, CPCs) capable of differentiating into cardio-
myocytes, endothelial cells and smooth muscle. The
putative function of these cells is to maintain normal
cardiac homeostasis and repair the heart after myocyte
loss (Bearzi et al. 2007; Kajstura et al. 2010).
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In rodents these cells have been identified by some
stem cell markers, such as c-Kit (CD117, the receptor
for stem cell factor), and Sca-1 (stem cell antigen-1)
(Oh et al. 2003). In experimental models of myocar-
dial infarction (MI) it has been reported that they may
differentiate into cardiomyocytes, endothelial and
vascular smooth muscle cells and improve myocardial
function (Beltrami et al. 2003).
However, it is difficult to obtain an adequate number
of CPCs for transplantation into the heart and several
approaches have been applied. One of them is based on
the observation that human and mice CPCs can self-
organize into three dimensional structures named cardi-
ospheres, that give origin to cardiomyoblasts and endo-
thelial and smooth muscle cells (Messina et al. 2004).
The observation that these cells, isolated from
human endomyocardial biopsies, have regenerative
potential (Smith et al. 2007) led to efficacy studies in
human ischemic heart diseases and heart failure. In
fact, the results of a randomized phase I–II clinical
trial have been recently reported (Makkar et al. 2012).
Growth and collection of an adequate number of CPC
for clinical trials or animal experiments demands at least
several weeks, and the use of complex culture media
containing growth factors and other components. For
example, the cardiosphere method consists of culturing
cardiac tissue fragments over fibronectin coated dishes
in a cardiac explant medium. After a period of
1–3 weeks a layer of fibroblast-like cells emerge from
adherent explants, over which small bright cells migrate.
These small cells are collected by gentle enzymatic
digestion and seeded in poly-D-lysine-coated wells in
cardiosphere-growing medium. 6–10 days later, sphere
clusters termed ‘‘cardiospheres’’ appear. Cardiospheres
are collected and plated on fibronectin-coated plates
where they form a monolayer of cells referred to as
cardiosphere-derived cells.
It is known that activated macrophages secrete
many growth factors in vitro, such as fibroblast growth
factor and insulin like growth factor (Fujiwara and
Kobayashi 2005; Hiruma et al. 2012; Oberlin et al.
2009). On this basis, we hypothesized that a feeder
layer of activated macrophages could provide the
factors needed for growing CPCs.
The possibility that activated macrophages may
provide a suitable milieu for growth and differentia-
tion of CPCs is supported by the observation that
during the first 2 weeks after an experimental MI,
coincident with the presence of a large number of
macrophages infiltrating the necrotic zone, there is
angiogenesis, arteriogenesis, replication of cardio-
myoblasts and entrance into the cell cycle of adult
cardiomyocytes in the border zone of the infarct (Vera
Janavel et al. 2006), phenomena similar to those
reported after injecting cardiosphere-derived CPCs in
experimental infarcts (Johnston et al. 2009).
We show herein that culture of isolated rat heart
cells on a feeder layer of activated syngeneic perito-
neal macrophages (PM) induces the formation of
spherical colonies that in successive passages give rise
to an almost pure monolayer of cells exhibiting
cardiocyte and smooth muscle phenotypes. When
injected in rats with coronary occlusion, these cells
decreased infarct size and improved heart function.
Materials and methods
Animals
Inbred 8-week old Wistar-Kyoto rats (School of
Veterinary Sciences, La Plata University, Argentina)
were used for the experiments.
All procedures were done in accordance with the
Guide for Care and Use of Laboratory Animals,
published by the US National Institutes of Health
(NIH publication no. 85-23, revised 1996) and approved
by the Laboratory Animal Care and Use Committee of
the Favaloro University, and by the Animal Welfare
Committee of La Plata University School of Medicine.
Macrophage collection
PM were obtained according to the technique reported
by Delgado et al. (1999). Briefly, rats received an
intraperitoneal injection of 12 ml of thioglycollate (Bri-
tania, Buenos Aires, Argentina). The peritoneal exudate,
collected 72 h later by puncture with a 25-gauge needle,
cFig. 1 a Image showing isolated myocytes (arrows) seeded on a
feeder layer of peritoneal macrophages. b After 1–2 weeks of
culture over a feeder layers of peritoneal macrophages, spheroidal
clusters measuring 50–1,500 lm in diameter were apparent.
c Isolated cell clusters composed of small brilliant cells, more
evident at the periphery. d After explant, those clusters developed
monolayers with cobblestone-like appearance. e–h Tissue section
of paraffin-embedded cell clusters showing positive cells with
orange stained cytoplasm after incubation with anti Sca-1 (e), anti
c-Kit (f), anti-smooth muscle actin (g) and anti-sarcomeric actin
(h) antibodies, post treated with peroxidase conjugated avidin and
revealed with EAC. Nuclei are stained bluewith hematoxylin and
the orange stain of the cell marker is located in the cytoplasm
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was diluted in Dulbecco’s Modified Eagle Medium
(DMEM) (Gibco, Invitrogen, Buenos Aires, Argentina)
containing 20 % foetal calf serum (FCS) (Internegocios
SA, Buenos Aires, Argentina), penicillin (2 %) / strep-
tomycin 2 % (Gibco). Cells were plated in 35 mm
diameter culture dishes (Corning, Corning, NY, USA) at
3 9 105 cells/cm2 for 2 h. After removal of non adher-
ent cells, the medium was replaced and the remaining
cells were cultured for 5 days in a 5 % CO2 atmosphere.
The medium was changed every other day. At least
96 % of the adherent cells were macrophages as judged
by morphological and phagocytic criteria.
Isolation and culture of CPCs
LV samples of male animals were minced into small
pieces and digested with type V collagenase (Sigma-
Aldrich, Buenos Aires, Argentina) for 2–3 min at
37 C under continuous fine tip pipetting. The proce-
dure was repeated until almost no heart fragments were
observed (7–8 times). After excluding the coarse tissue
fragments by spontaneous sedimentation at 1G the
supernatant was centrifuged at 700 RPM, washed twice
with PBS and plated for 2 h in 60 mm diameter culture
dishes (Corning) with complete medium, to decrease
fibroblast contamination. The supernatant was trans-
ferred to tissue culture plates containing the adherent
PM or to tissue culture plates with no PM feeder layer
as control. Figure 1a shows isolated cardiac myocytes
seeded on a feeder of PM.
After 24 h the supernatant containing non-adherent
cells, including viable and necrotic cardiomyocytes, was
discarded. As a result, no cardiocytes were observed in
the cultures. Cells were kept in DMEM containing 20 %
FCS which was changed every 2 days. After 5–6 days,
at 80–90 % of confluence, spherical clusters variable in
diameter composed of small bright and spherical cells
loosely attached to the tissue culture plate were apparent
(Fig. 1b). Following mechanic disruption by continuous
pipetting through a fine tip pipette and mild treatment
with trypsin–EDTA (Gibco) in order to prevent contam-
ination with adherent macrophages, the clusters were
transferred to tissue culture flasks (T75, Corning). After
2–3 passages, cells were collected for the experiments.
Inmunocytochemical studies
The spherical colonies were fixed in 4 % buffered
formaldehyde, embedded in paraffin and sectioned at
5 lm.Cellmonolayerswerefixed in cold methanolor4 %
buffered formaldehyde. Primary antibodies used were anti
Flk-1, connexin 43 (Santa Cruz Biotech., Santa Cruz, CA,
USA), sarcomeric actin, desmin, c-Kit (Novocastra/Leica,
Newcastle upon Tyne, UK), Sca-1 (Bioscience, San Jose,
CA, USA), a-smooth muscle actin, vimentin and cytoker-
atin (Biogenex, San Ramon, CA, USA).
After incubation with the primary antibody, cell
monolayers were post-incubated with biotinylated
anti-mouse immunoglobulins: (Vector Labs, Peter-
borough, UK) and post-treated with fluorescein
labelled avidin (Vector Labs, Peterborough, UK).
After nuclear staining with DAPI, cells were examined
with a fluorescence microscope. The paraffin-embed-
ded tissue sections were incubated with the same
antibodies but instead of using fluorescein labelled
avidin they were incubated with peroxidase conju-
gated avidin and revealed with EAC (Biogenex).
Nuclei were stained with hematoxylin.
Bright field images and fluorescent images were
obtained using a Zeiss Axiophot microscope equipped
with an Axiocam Zeiss camera.
Cell labeling for location of the injected cells
To track the transplanted cells we used as tracer the
fluorescent dye PKH26 (Sigma Aldrich), which mainly
binds to the cell membrane. Labeling was performed
according to the manufacturer’s protocol. Briefly, cells
detached by trypsin treatment were washed with
serum-free medium, resuspended in dilution buffer
from the manufacturer’s kit, mixed with a solution
containing PKH26 and incubated for 5 min at room
temperature. After ending the reaction by adding 2 ml
FCS, cells were washed three times with DMEM and
observed by fluorescence microscopy. As can be seen
in Fig. 3a, b, most cells were labeled.
Surgical procedures and cell implantation
MI was produced in female inbred Wistar-Kyoto rats
weighing 220–250 g by left coronary artery occlusion
with a 7–0 silk suture under mechanical ventilation.
The presence of infarct was verified by pallor at the
apex. Ten minutes after ligation, animals (n = 6) were
injected intramyocardially with 160 ll of phosphate
buffered saline (PBS) containing 1 9 106 CPCs,
collected from the cobblestone-like cell culture,
divided into three equal aliquots in the peri-infarct
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zone. Control animals (n = 6) were similarly injected
with 160 ll PBS. Four additional animals received the
same amount of CPCs labeled with PKH26. Six sham-
operated rats underwent thoracotomy and heart expo-
sure but no coronary artery ligation. Three weeks later,
an echocardiogram was performed. Immediately after
the procedure, the animals were euthanized and the
hearts removed for histological studies.
Histological studies
The hearts were immersed in 10 % buffered formalde-
hyde for 48 h and sectioned transversally to the main
axis in three slices, one at 1 mm from the atrioventric-
ular sulcus, one at 1 mm from the apex, and one mid
way between the apex and the atrioventricular sulcus.
Slices were embedded in paraffin. Tissue sections
measuring 3 lm in thickness were stained with hema-
toxylin-eosin and trichrome. Scar size and infarcted
wall thickness were determined on Masson’s trichrome
stained sections with a morphometry analysis system
(Image ProPlus 4.5, Media Cybernetics, Rockville,
MD, USA).
The hearts of the rats injected with the PHK26
labeled cells were sectioned at the middle of the LV, and
snap frozen in liquid nitrogen. Five micrometer sections
Fig. 2 Immunofluorescent images of the monolayers. Nuclear
stain with DAPI. a Almost all cells were stained with an anti-
desmin antibody. b At higher magnification, the longitudinally-
oriented smooth muscle actin filaments are apparent. c Sarco-
meric actin striated sarcomeres. d The same cell in c with no
nuclear stain, showing more clearly the sarcomeric actin
filaments. e Almost all cells in the monolayer show in their
surfaces numerous punctated areas intensely stained after
incubation with an anti-connexin 43 antibody. f Higher mag-
nification of connexin 43-positive structures
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obtained with a cryostat were counterstained with DAPI
and examined with a fluorescence microscope.
Echocardiographic studies
Under superficial anesthesia, transthoracic 2D guided
M-mode echocardiography was performed. Measure-
ments were averaged from five consecutive cycles.
From a short axis at the level of the papillary muscles,
LV end-diastolic dimension (EDD) and volume
(EDV), and end-systolic dimension (ESD) and volume
(ESV), interventricular septum thickness at end sys-
tole (SST), and end diastole (SDT), anterior wall
thickness (AWT), fractional shortening (FS) and
ejection fraction (EF), calculated as EF = 100 9 (L-
VEDV-LVESV)/LVEDV, were recorded.
Statistical analysis
Continuous variables are reported as mean ± SD. Differ-
ences between continuous variables were analyzed with
one-way ANOVA followed by Scheffe´’s test. A p value
\0.05 (2-sided) was considered significant. Statistical
analysis was performed with SPSS11.0 software (SPSS
Inc, Chicago, IL, USA).
Results
Cardiac progenitor cells isolation, culture
and phenotypic characterization
One to two weeks-old cultures of isolated LV cells
showed spheroidal clusters composed of small bril-
liant round cells measuring 50–1,500 lm in diameter
on the feeder layer of activated PM (Fig. 1b, c). They
were loosely attached and could be collected mechan-
ically by pipetting or by mild trypsin incubation. At
that time no cardiomyocytes were present in the plates,
on account that they had been removed during the
previous washings. In control plates seeded with the
heart suspension but without PM feeder layer, no
adherent cells were observed at 1 week after culture,
and only a few spherical isolated cardiocytes were
floating in the culture medium.
Culture of the cell clusters in uncoated plasticware
with DMEM containing 20 % FCS produced monolayers
of cells with cobblestone-like shape that were success-
fully maintained for more than ten passages (Fig. 1d).
The immunohistochemical study of paraffin
embedded spherical colonies revealed that they were
composed of a cell population expressing stem cell
markers (Sca-1 and c-Kit) and scarce cells with
smooth muscle and myocyte markers (Fig. 1e–h).
Labelled cells were distributed at random mostly in the
periphery of the cell colonies, and apparently there
were no differences between small and large colonies.
Almost all cells in the monolayers displayed desmin
filaments in their cytoplasm (Fig. 2a). For each culture,
a variable proportion of cells expressed smooth muscle
actin (Fig. 2b) or the cardiac marker sarcomeric actin,
with many of them showing clear-cut sarcomeres
(Fig. 2c, d). In addition, most cells expressed connex-
in-43 in their surface (Fig. 2e, f). The search of
cytokeratin, a cytoplasmic marker for mesothelial cells,
and of Flk-1 for endothelial cells, was consistently
negative. Beating cells were never observed.
Fate of injected CPCs
As can be seen in Fig. 3c, at 21 days after injection
many cells labeled with PKH26 were present in the
peri-infarct area. Some of the labeled cells displayed
cytoplasmic sarcomeric actin, but were smaller than
the neighboring native cardiocytes.
Changes in infarct size and LV morphometry
At 3 weeks after MI, morphometric analysis of
explanted hearts from control animals showed
increased size of the collagen scar and infarct wall
thinning as compared with animals receiving synge-
neic myoblasts (Fig. 3d–f).
bFig. 3 a and b Cell labeling for location of the injected cells:
under Nomarski optics, all cells appear stained with PKH26. c At
21 days after implantation, many labeled cells derived from the
monolayers, with sarcomeric actin-positive cytoplasm (small
arrow), are present in the interstitium and in the neighborhood of
heart muscle cells (large arrow) (Masson’s trichrome stain).
d Transversal sections of hearts from a PBS-treated mouse (upper)
and a CPC-treated mouse (lower) at 21 days after ligature of the
left coronary artery: the difference in the size of the infarcted area
(blue) between injected with CPCs and PBS is apparent. e Infarct
size was significantly smaller in mice injected with CPCs.
f Infarcted wall thickness was significantly higher in CPC-treated
mice. g–j Left ventricular function: at 3 weeks after treatment,
CPC-treated mice displayed lower systolic diameter (g), higher
systolic wall thickness (h), higher ejection fraction (i) and higher
fractional shortening (j) than mice injected with PBS
Cytotechnology (2016) 68:665–674 671
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LV function
Cardiac function results are shown in Fig. 3g–f. At
3 weeks after MI, the group receiving CPCs showed,
as compared with the PBS group, higher FS
(35.63 ± 1.81 vs. 29.72 ± 4.27 %, p\ 0.05), EF
(53 ± 3.5 vs. 43 ± 6.3 %, p\ 0.01) and SST
(1.65 ± 0.03 vs. 1.36 ± 0.03 mm, p\ 0.01). On the
other hand, LVESD was lower in CPCs than in PBS
animals (2.38 ± 0.28 vs. 2.89 ± 0.47 mm, p\ 0.01).
LVEDD and AWT showed no significant differences
among the groups.
Discussion
The discovery in the adult heart of a reservoir of
progenitor cells, able to renew themselves and differ-
entiate into multilineage phenotypes (Beltrami et al.
2003) has provided a new approach for cardiac cell
therapy after MI (Barile et al. 2007).
The expression of specific cell surface markers,
such as c-Kit or Sca-1, permitted their isolation by cell
sorting and amplification by posterior growth in
specific culture media. Transplantation of Sca-1
derived cells in experimental infarction induces angi-
ogenesis and neomyogenesis with improvements in
cardiac function (Tang et al. 2007; Wang et al. 2006)
and intramyocardial injection of c-Kit derived cells in
the infarct border zone induces cardiac regeneration
including muscle and vessel neoformation (Hosoda
2012).
Recently, these cells have been employed in a
clinical trial of patients with heart failure of ischemic
etiology undergoing coronary artery bypass surgery.
The results showed improvement in both global and
regional LV function, infarct size reduction and
increased viable tissue (Bolli et al. 2011).
CPCs in amounts adequate for experiments and
clinical trials can also be obtained by the cardiosphere
method. Messina et al. (2004) and Smith et al. (2007)
demonstrated that small cardiac explants cultured on
poly-D-lysine induce the appearance of self-assem-
bling spherical clusters termed cardiospheres, com-
posed of undifferentiated and cardiac-committed cells.
When they are re-plated and expanded in monolayer
cultures, a relevant number of cardiosphere-derived
cells are obtained. When injected into experimental
infarcts, these cells engraft in the injured heart,
differentiate, secrete pro-angiogenic/cardiogenic
cytokines and confer functional benefits.
A recent phase I–II clinical study of intracoronary
cardiosphere-derived cells in patients with recent
acute MI and LV dysfunction showed promising
results (Makkar et al. 2012).
On account that in experimental MI intracardiac
stem cells, especially those derived from cardio-
spheres, provide the greatest functional benefit when
compared with extracardiac stem cells (Li et al. 2012),
developing new approaches for culturing intracardiac
stem cells is of interest.
Our results show that culturing isolated rat heart cells
on a feeder layer of syngeneic PM induces the
appearance of cell clusters resembling the cardiospheres
described by Messina et al. (2004). Their expansion in
monolayers produced cells expressing differentiation
markers of cardiocyte and smooth muscle lineages such
as smooth muscle actin, desmin, sarcomeric actin and
connexin 43. In addition, they decreased the scar size
and improved function in experimental MI. Apparently,
many cells survived 21 days after injection, as shown by
the labeling experiments.
Despite some differences, all reported techniques
used to obtain CPCs demand complex differentiation
media containing several growth factors, such as basic
fibroblast growth factor, leukemia inhibitory factor,
epidermal growth factor, cardiotropin-1, thrombin and
synthetic media for growth of Sca-1 cells or for
cardiospheres (Smith et al. 2007; Shenje et al. 2008;
Andersen et al. 2009; Li et al. 2009; Ling et al. 2013).
Apparently, the feeder layer of activated macro-
phages made unnecessary the incorporation of those
products to the culture medium. Although it is known
that activated macrophages, especially those belong-
ing to the M2 subpopulation, secrete cytokines and
growth factors engaged in angiogenesis and tissue
repair (Fujiwara and Kobayashi 2005; Oberlin et al.
2009; Hiruma et al. 2012), the factors that may induce
the formation of CPCs and cells with cardiac pheno-
types were not investigated in the present work. It is
known that macrophages, derived either from perito-
neum or from circulating monocytes only proliferate
in culture when provided with growth factors (van der
Zeist et al. 1978; Genovesi et al. 1989). Since in our
experiments the macrophage culture was not irradi-
ated, we could not discard the possibility that the
incorporation and posterior growth of heart-derived
cells could provide growth factors able to induce
672 Cytotechnology (2016) 68:665–674
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macrophage proliferation. However, the fact that the
cell clusters and monolayers contained cells with stem
cell and smooth and heart muscle markers, which are
not expressed by macrophages, makes that possibility
unlikely.
However, once the cell clusters were re-plated in
uncoated tissue culture flasks, only conventional tissue
culture media and FCS were required for culture
expansion.
The cell clusters obtained in the primary culture of
isolated heart cells on syngeneic macrophages showed
some phenotypic characteristics similar to the cardi-
ospheres described by Messina et al. (2004) such as
expression of the stem cell markers c-Kit and Sca-1. In
addition, some cells showed smooth muscle actin and
sarcomeric actin markers, but in contrast with the
expanded cardiosphere-derived progenitors, neither
cells with endothelial markers nor fully differentiated
cardiocytes or beating cells were observed.
In summary, the present study shows that a
suspension of isolated heart cells grown on a feeder
layer of syngeneic activated PM yields cells belonging
to the cardiac and smooth muscle lineages, and that
these cells, in turn, can decrease scar size and improve
myocardial function in rats with MI. The approach
used permits obtaining CPCs in adequate amount for
experiments at low cost and reasonable simplicity,
suggesting that it could be possibly employed for
isolation and differentiation of stem cells of other
tissues and organs.
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